aripiprazole
aripiprazole: 4 clinical trials tracked.
aripiprazole evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about aripiprazole, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (4)
A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Monotherapy Study to Evaluate Efficacy of Roluperidone on Negative Symptoms in Adult Subjects With Schizophrenia, Followed by a 52-Week, Randomized, Double-Dummy Phase to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Primary endpoint: Change from Baseline to Week 12 in Marder Negative Symptoms Factor Score (NSFS)
A Prospective, Matched-Control, Randomized, Open-Label, Flexible-Dose, Study in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics
Primary endpoint: Part-2 (Disease Progression): Time to First Treatment Failure
REFRESH : Randomized Double-blind, Placebo-controlled, Multicenter Trial to Assess the Safety and Efficacy of RP5063 in Subjects With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
Primary endpoint: Measurement of Schizophrenia Symptoms: Positive and Negative Syndrome Scale (PANSS) Total Score
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
Primary endpoint: Triglyceride/High-density Lipoprotein (TG/HDL) Ratio